177 related articles for article (PubMed ID: 9210893)
1. New drugs for the treatment of lung cancer. The Tokyo Cooperative Oncology Group.
Niitani H; Fukuoka M; Furuse K; Kudoh S; Kurita Y; Ohnoshi T; Saijoh N
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():117-9. PubMed ID: 9210893
[No Abstract] [Full Text] [Related]
2. New drug for therapy of non-small cell lung cancer.
Klastersky J
Lung Cancer; 1994 Nov; 11 Suppl 3():S139-49. PubMed ID: 7704506
[No Abstract] [Full Text] [Related]
3. The role of new agents in advanced non-small-cell lung carcinoma.
Langer CJ
Curr Oncol Rep; 2000 Jan; 2(1):76-89. PubMed ID: 11122828
[TBL] [Abstract][Full Text] [Related]
4. [New cytostatics in the therapy of non-small cell bronchial carcinoma].
Serke M; Schönfeld N; Loddenkemper R
Pneumologie; 1998 Jun; 52(6):333-7. PubMed ID: 9715648
[No Abstract] [Full Text] [Related]
5. Promising new agents in the treatment of non-small cell lung cancer.
Edelman MJ; Gandara DR
Cancer Chemother Pharmacol; 1996; 37(5):385-93. PubMed ID: 8599859
[TBL] [Abstract][Full Text] [Related]
6. Treatment of metastatic non-small cell lung cancer.
van Zandwijk N; Giaccone G
Curr Opin Oncol; 1996 Mar; 8(2):120-5. PubMed ID: 8727304
[TBL] [Abstract][Full Text] [Related]
7. New chemotherapeutic agents for non-small cell lung cancer.
Miller VA; Rigas JR; Grant SC; Pisters KM; Kris MG
Chest; 1995 Jun; 107(6 Suppl):306S-311S. PubMed ID: 7781411
[TBL] [Abstract][Full Text] [Related]
8. [New drugs in gastrointestinal oncology. Current status and future directions].
Conroy T; Paillot B; Adenis A
Gastroenterol Clin Biol; 1999 Nov; 23(11):1145-65. PubMed ID: 10651534
[No Abstract] [Full Text] [Related]
9. Radiosensitization with chemotherapeutic agents.
Caffo O
Lung Cancer; 2001 Dec; 34 Suppl 4():S81-90. PubMed ID: 11742709
[TBL] [Abstract][Full Text] [Related]
10. [New wave of chemotherapeutic agents: update in pulmonary oncology].
Sculier JP
Rev Mal Respir; 1997 Apr; 14(2):154-6. PubMed ID: 9198842
[No Abstract] [Full Text] [Related]
11. [New promising anticancer drugs for lung cancer].
Ariyoshi Y; Sugiura T
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2578-84. PubMed ID: 7979416
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients.
Franciosi V; Barbieri R; Aitini E; Vasini G; Cacciani GC; Capra R; Camisa R; Cascinu S
Lung Cancer; 2003 Jul; 41(1):101-6. PubMed ID: 12826318
[TBL] [Abstract][Full Text] [Related]
13. Management of elderly patients with lung cancer.
Ranson MR; White S; Thatcher N
Curr Oncol Rep; 2000 Jan; 2(1):90-5. PubMed ID: 11122829
[TBL] [Abstract][Full Text] [Related]
14. 20th-century advances in drug therapy in oncology--Part. II.
Dutcher JP; Novik Y; O'Boyle K; Marcoullis G; Secco C; Wiernik PH
J Clin Pharmacol; 2000 Oct; 40(10):1079-92. PubMed ID: 11028247
[TBL] [Abstract][Full Text] [Related]
15. Rationale for non-platinum chemotherapy in advanced NSCLC.
Murren JR
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
[TBL] [Abstract][Full Text] [Related]
16. New drugs for treating small cell lung cancer.
Ettinger DS
Lung Cancer; 1995 Jun; 12 Suppl 3():S53-61. PubMed ID: 7551957
[TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced disease and new drugs.
Frustaci S; Buonadonna A; La Mura N; Berretta M; De Paoli A
Suppl Tumori; 2003; 2(5):S48-50. PubMed ID: 12914391
[No Abstract] [Full Text] [Related]
18. A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.
Kosmas C; Tsavaris N; Syrigos K; Koutras A; Tsakonas G; Makatsoris T; Mylonakis N; Karabelis A; Stathopoulos GP; Kalofonos HP
Cancer Chemother Pharmacol; 2007 Jan; 59(1):51-9. PubMed ID: 16622691
[TBL] [Abstract][Full Text] [Related]
19. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
20. Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.
Meert AP; Berghmans T; Branle F; Lemaître F; Mascaux C; Rubesova E; Vermylen P; Paesmans M; Sculier JP
Anticancer Res; 1999; 19(5C):4379-90. PubMed ID: 10650780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
